Insider Transactions in Q1 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,886
-1.82%
|
$331,936
$176.6 P/Share
|
|
Jan 31
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
163
-0.06%
|
$28,688
$176.6 P/Share
|
|
Jan 29
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,335
-1.01%
|
$719,610
$166.47 P/Share
|
|
Jan 29
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
13,685
-1.29%
|
$2,271,710
$166.61 P/Share
|
|
Jan 29
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
4,030
-0.92%
|
$668,980
$166.38 P/Share
|
|
Jan 29
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
5,201
-1.24%
|
$863,366
$166.37 P/Share
|
|
Jan 29
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,773
-0.73%
|
$792,318
$166.31 P/Share
|
|
Jan 29
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
6,003
-0.13%
|
$996,498
$166.61 P/Share
|
|
Jan 29
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
1,054
-0.2%
|
$174,964
$166.51 P/Share
|
|
Jan 27
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,442
-1.32%
|
$232,162
$161.87 P/Share
|
|
Jan 27
2025
|
Jonathan Sheena |
SELL
Bona fide gift
|
Direct |
588
-0.22%
|
-
|
|
Jan 24
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
946
-0.43%
|
$162,712
$172.12 P/Share
|
|
Jan 23
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
495
-0.45%
|
$84,645
$171.09 P/Share
|
|
Jan 22
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
21,228
-6.3%
|
$3,566,304
$168.46 P/Share
|
|
Jan 22
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
24,861
-7.51%
|
$4,176,648
$168.45 P/Share
|
|
Jan 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.11%
|
-
|
|
Jan 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,931
-9.57%
|
$4,356,408
$168.45 P/Share
|
|
Jan 22
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
78,553
-11.35%
|
$13,196,904
$168.46 P/Share
|
|
Jan 22
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,039
-4.6%
|
$3,702,552
$168.45 P/Share
|
|
Jan 22
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
971
-0.18%
|
$163,128
$168.43 P/Share
|
|
Jan 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+0.84%
|
-
|
|
Jan 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,775
+0.51%
|
-
|
|
Jan 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.27%
|
-
|
|
Jan 21
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
144
+0.05%
|
-
|
|
Jan 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+1.12%
|
-
|
|
Jan 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+0.97%
|
-
|
|
Jan 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.36%
|
-
|
|
Jan 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
191
+0.07%
|
-
|
|
Jan 16
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,730
+23.01%
|
-
|
|
Jan 16
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
24,348
+20.71%
|
-
|
|
Jan 16
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
101,812
+22.99%
|
-
|
|
Jan 16
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
54,175
+18.47%
|
-
|
|
Jan 16
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
54,316
+10.54%
|
-
|
|
Jan 16
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
48,548
+9.43%
|
-
|
|
Jan 16
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
24,832
+9.44%
|
-
|
|
Jan 16
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,696
+6.03%
|
-
|
|
Jan 16
2025
|
Jonathan Sheena |
BUY
Grant, award, or other acquisition
|
Direct |
4,966
+1.86%
|
-
|
|
Jan 16
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
3,043
+1.17%
|
-
|
|
Jan 08
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,223
-3.02%
|
$1,089,025
$175.3 P/Share
|
|
Jan 02
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.09%
|
$477,000
$159.72 P/Share
|
|
Jan 02
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.35%
|
$429,300
$159.68 P/Share
|